trending Market Intelligence /marketintelligence/en/news-insights/trending/zxaQb4CJNSOD_ogwCMoXmw2 content esgSubNav
In This List

Axia Pharmaceutical recalls all unused sterile drugs

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond


Axia Pharmaceutical recalls all unused sterile drugs

Fusion IV Pharmaceuticals Inc., doing business as Axia Pharmaceutical, is recalling all unused sterile drug products within expiry due to uncertainty about the products being germ-free.

The Los Angeles-based company said the recalled products were found to be inconsistent with federal guidelines. The use of such products risks serious infections, which can be potentially life-threatening.

The company has asked users to stop using the recalled products and return them to Axia Pharmaceutical.

Axia Pharmaceutical added that there are no reports of any adverse events related to this recall, which is being conducted with the knowledge of the U.S. Food and Drug Administration.